Navigation Links
'Bacillus anthracis and Anthrax'
Date:1/12/2011

Few strands of bacteria have achieved such a central place in public consciousness as Bacillus anthracis, the bacteria which causes Anthrax. While today it is a feared weapon of bioterrorism Bacillus anthracis has played a significant historical role, especially through the research of the celebrated 19th century scientists Robert Koch and Louis Pasteur, in shaping our understanding of infectious diseases and immunology

In his new book Bacillus Anthracis and Anthrax Dr Nicholas Bergman brings both of these perspectives together to present a definitive 'state of the field' summary for anthrax research, providing a comprehensive guide to all aspects of the organism, ranging from basic biology to central public health issues.

"With all the attention and research that have been focused on Bacillus anthracis and anthrax in recent years, our understanding of both the organism and the disease has improved dramatically," said Bergman. "This book aims to provide a up-to-date reference that will be useful to scientists, medical and public health personnel, and those playing roles in shaping public policy."

Bacillus Anthracis and Anthrax covers all major aspects of Anthrax biology, from basic biology and pathogenesis to diagnosis, treatment, and prevention of anthrax bioterror-associated issues.

Throughout the book anthrax is considered historically as well biologically, with chapters ranging from the impact of anthrax on human history from 5000 BC by Peter Turnbull and Sean Shadomy, to an assessment of current anthrax vaccination research by Elke Saile and Conrad Quinn, as well as an analysis by Leonard Cole of anthrax as a weapon of war.

The biological analysis of B. anthracis, includes research on life cycle, differentiation, cellular structure, as well as the interaction of B. anthracis with the immune system.

Bacillus Anthracis and Anthrax also considers the clinical features, diagnosis and treatment of the different forms of human anthrax, as well as a review of animal models of anthrax and their use in research.

While Bacillus Anthracis and Anthrax will be a premier reference tool to B. Anthracis and anthrax for microbiologists, immunologists and physiologists it will also serve as an invaluable resource for medical professionals, bioterror experts and all those involved in the issues of public health.


'/>"/>

Contact: Ben Norman
Lifesciencenews@wiley.com
44-012-437-70375
Wiley-Blackwell
Source:Eurekalert

Related medicine news :

1. Poll: Hypothetical anthrax attack and antibiotics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance ... care insurance companies have a waiver for care if the client has a cognitive ... the family pays for care, is often waived, so the benefits from their insurance ...
(Date:10/13/2017)... Texas (PRWEB) , ... October 13, 2017 , ... Yisrayl ... this week that explains one of the most popular and least understood books in ... like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history ... The Brink” is the creation of published author, William Nowers. Captain Nowers and ... WWII veteran, he spent thirty years in the Navy. Following his career as ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... Israel and NEW YORK , Sept. 27, ... with mobile health and big data solutions, today announced that its MyDario ... Please check your local TV listings for when The Dr. Oz Show ... ... season this month. ...
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
(Date:9/19/2017)... Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses ... today:   ... Jim ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and business ...
Breaking Medicine Technology: